Medical Humidifier Companies

The medical humidifier market is projected to reach USD  1,211.7 million by 2029 from USD 922.8 million in 2024, at a CAGR 5.6% from 2024 to 2029.

Medical humidifiers are devices used in healthcare environments to add moisture to the air or to medicinal gases, therefore guaranteeing sufficient humidification for patients undergoing ventilation, oxygen therapy, or other respiratory therapies. These devices lessens discomfort, helps avoid dryness in the respiratory tract, and thereby raise patient comfort and treatment effectiveness. The major factors driving the market growth of  the medical humidifier market include rising prevalence of chronic obstructive pulmonary disease  (COPD), asthma, and respiratory distress syndrome (RDS), rise in the geriatric population is leading to an increased incidence of respiratory ailments, increasing adoption of ventilators in ICUs and for home care patients, and government initiatives to expand healthcare infrastructure in developing regions.

To know about the assumptions considered for the study download the pdf brochure

The market players have adopted various strategies such as development of advanced products, agreement, and expansions to strengthen their position in the medical humidifier market. For instance, In August 2024, Fisher & Paykel Healthcare introduced the F&P my820, a respiratory humidifier designed for home mechanical ventilation. The F&P my820 system delivers heated humidification for a range of respiratory support therapies, including invasive ventilation, noninvasive ventilation (NIV), and humidified high-flow therapies for adult and pediatric patients. In november 2023, Vincent Medical Holdings Limited inaugurated a new  R&D and production facility in China which will serve as the R&D and production base of the Group.

Some of the prominent players operating in the market include ResMed Inc. (US), Drägerwerk AG & Co. KGaA (Germany), Fisher & Paykel Healthcare Limited (New Zealand), Koninklijke Philips N.V. (Netherlands), Vincent Medical Holdings Limited (Hong Kong), Medline Industries, LP. (US), Hamilton Medical (Switzerland), GaleMed Corporation (Taiwan),  and Eakin Healthcare (UK) among others.

Fisher & Paykel Healthcare Limited (New Zealand)

Fisher & Paykel Healthcare Limited designs, manufactures, and markets products for respiratory care, acute care, and obstructive sleep apnea. The company primarily operates in three business segments: Hospital Products, Homecare Products, and Distributed and Other Products. The Hospital Products segment offers medical humidifier products. . They invest in research & development which helps in driving innovation and enhancing patient outcomes. By leveraging their huge product portfolio and global reach, they are  maintaining dominance in the medical humidifier market across various geographies and healthcare settings. Fisher & Paykel Healthcare operates in over 120 countries worldwide. It adopted product launches and expansion as key strategies to increase its revenue. The recently launched F&P my820 system delivers heated humidification for a range of respiratory support therapies.

ResMed Inc. (US)

Leading worldwide in digital health, sleep apnea treatment, and respiratory care solutions, ResMed Inc. is also strongly apparent in ventilation and humidification technology. Together with continuous positive airway pressure (CPAP) devices, the firm designs and produces medical humidifiers, along with life support ventilators and bilevel positive airway pressure (BiPAP) devices. Two main divisions define the activities of the company: Sleep and Respiratory Care and Software as a Service (SaaS). Essential for the medical humidifiers market, the Respiratory Care section provides solutions meeting different patient needs. Serving sleep clinics, home healthcare providers, patients, and third-party payers, the company's product range is offered in over 140 countries. Maintain its market share in respiratory care equipment, the company emphasizes on organic and inorganic development plans. For example, ResMed acquired Tong-il (South Korea), another top HME provider in South Korea for respiratory care and sleep.

Drägerwerk AG & Co. KGaA (Germany)

With its headquarters in Lübeck, Germany, Drägerwerk AG & Co. KGaA is globally recognised pioneer in medical and safety solutions. The Medical section consists of system solutions, tools, and services for acute point-of- care needs. Maintaining sales and service operations in almost 50 countries, the company ensures a wide visibility. Drägerwerk AG & Co. KGaA continues to prioritize innovation in product development and manufacturing medical humidifiers that satisfy the requirements for efficiency, patient comfort, and simplicity of use as their top priorities. The company demonstrates an immense will to develop its technology since it invested around USD 348.57 million in R&D in 2023. Securing 278 fresh patents over the fiscal year, it demonstrated its leadership in creating fresh ideas. These patents confirm even more the company's role as a medical equipment innovator.

Related Reports:

Medical Humidifier Market by Product (Heated, Heat & Moisture Exchangers, Humidifier Accessories), Application (ICUs , Neonatal Care),Distribution Channel (Online), Patient Type (Adult), End user (Hospitals) and Region - Global Forecast to 2029

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA : 1-888-600-6441
[email protected]